-

eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency

Innovation allows for real-time data and operational insights to advance immunology breakthroughs

BOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced that argenx SE, a global immunology company, is expanding adoption of the elluminate Clinical Data Cloud® to improve and enhance clinical data processes.

The elluminate platform is designed to improve access to and analysis of clinical trial data across sources with a central source of communication for clinical data, including Data Central for collaborative data review across sources, Clinical Analytics for self-service data visualization and analysis, Sample Management Analytics for tracking of external data, and Protocol Deviations for trial oversight and compliance. elluminate eIQ Review, an AI-enabled data review and query automation system, and machine learning (ML)-driven Audit Trail Review integrates more advanced capabilities. This approach aims to help reduce cycle times through improved data quality.

“We’re excited to continue supporting argenx’s commitment to future-proofing clinical trials with a modern data infrastructure,” says Raj Indupuri, CEO and co-founder at eClinical Solutions. "The expanded collaboration will aid argenx in innovating their data operations, enhance collaboration and data quality, and accelerate time to market in support of their vision to reach more patients with breakthrough science.”

For more information on eClinical Solutions’ AI-enabled elluminate platform, click here.

About eClinical Solutions LLC
eClinical Solutions’ industry-leading clinical data intelligence platform, elluminate®, and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations develop tomorrow’s breakthroughs with today’s resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplace USA Award: Remote Work, the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, and Great Place To Work® India Certification™. Learn more at http://www.eclinicalsol.com/ and follow eClinical Solutions on LinkedIn.

Contacts

Media
Olivia Mannion
eclinical@pancomm.com

eClinical Solutions LLC


Release Versions

Contacts

Media
Olivia Mannion
eclinical@pancomm.com

Social Media Profiles
More News From eClinical Solutions LLC

eClinical Solutions and Hobson & Company Quantify Financial and Operational Value of a Clinical Data Intelligence Platform for Clinical Trials

BOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced the results of a collaboration with Hobson & Company, a research firm specializing in Return on Investment (ROI) studies, to test and confirm the sources of value generated by the elluminate® Clinical Data Intelligence Platform, the company’s comprehensive AI-powered clinical data and analytics solution. Based on in-depth interviews with eClinical Solutions clients,...

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

BOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced two additions to its C-suite with the hiring of Lauren Whitsell as Chief Operating Officer and appointment of Venu Mallarapu as Chief Transformation and AI Officer. The news comes following a growth investment from GI Partners, signaling strong momentum as the company deepens its product roadmap, further embedding AI and risk-based capabilities, and ensures future-ready...

eClinical Solutions Highlights 2025 Achievements and Announces Latest Innovations to Accelerate and Future-Proof Clinical Trials

BOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced 2025 milestones along with new 2026 innovation to support the end-to-end clinical research lifecycle, bringing breakthrough therapies to patients faster. Last year the company added over 20 net new customers to its portfolio of biopharma and CRO clients, which now includes 18 of the top 50 pharmaceutical companies in the world, supporting clinical trial leaders with an...
Back to Newsroom